VIRTUAL | November 1-3, 2021

 

Identifying and Advancing Novel Pain Drugs Through Clinical Development and Commercialization

2012 Speakers

CHAIRPERSON: William K. Schmidt, Ph.D., President, NorthStar Consulting, LLC, VP Clinical & Regulatory, Arcion Therapeutics, VP Clinical Development, CrystalGenomics (CG Pharmaceuticals)

Allan Basbaum, Ph.D., Professor & Chair, Department of Anatomy, University of California, San Francisco

Mark T. Brown, MD, Executive Director, Clinical Program Leader for Osteoarthritis and Cancer Pain Studies, Pfizer Inc.

Robert Bianchi, VP & Chief of Scientific and Technical Affairs, Prescription Drug Research Center

Dr. Michael Graham, Chief Scientist, Benitec Biopharma

Nathaniel P. Katz, MD, MS, President & CEO, Analgesic Solutions

Ernest A. Kopecky Ph.D, MBA, VP Clinical Development, Head, Neuroscience TA, COLLEGIUM PharmaceuticalResearch Fellow, Division of Clinical Pharmacology/Toxicology, Hospital for Sick Children

Michael LaCroix-Fralish, Ph.D., Staff Scientist, Pain Therapeutics Group, Regeneron Pharmaceuticals

Michael S. Leong, MD, Clinic Chief, Stanford Pain Medicine Center, Clinical Associate Professor, Anesthesia, Stanford University

Sean Mackey, MD, Ph.D., Chief, Division of Pain Management, Stanford University School of Medicine, Associate Professor of Anesthesiology, Director, Stanford Systems Neuroscience & Pain Lab

Donald C. Manning, MD, Ph.D., Chief Medical Officer, Adynxx Inc.

Robert Medve, MD, Senior Vice President & Chief Medical Officer, Nektar Therapeutics

Brian Meltzer, MD, Executive Director, R&D Innovation, Purdue Pharma

Steve Miller, Ph.D., Senior Director, Translational Medicine, Array BioPharma

Magdalene Moran, Ph.D., Vice President, Biology, Hydra Biosciences

Markus Muttenthaler, Ph.D., Departments of Chemistry and Cell Biology, The Scripps Research Institute

Daniela Salvemini, Ph.D., Professor, Saint Louis University School of Medicine

Neil Singla, MD, Founder & Chief Scientific Officer, Lotus Clinical Research, LLC

David Upmalis, MD, Senior Director and Compound Development Team Leader, fulranumab, Janssen Research Foundation

Lynn Webster, MD, Medical Director, CRI Lifetree, President-Elect, The American Academy of Pain Medicine

Tony L. Yaksh, Ph.D., Professor and Vice Chair for Research, Department of Anesthesiology and Professor of Pharmacology, University of California, San Diego

Organized and Produced by

 

Join our Social Media Groups

  
Pain Drug Development Group
                  
@PainConference

Conference Twitter Feed

About Us

Arrowhead Publishers' conferences offer more than simply presentations; we offer an experience that encompasses learning, networking and professional growth. We focus on bringing life sciences industry professionals together to help move research forward. 
READ MORE

Contact Us

For general information about the conference, please contact us at:
 This email address is being protected from spambots. You need JavaScript enabled to view it.
 +866.945.0263
 +866.945.0263
  PO Box 96, Chanhassen, MN 55317 USA

PRIVACY POLICY